Literature DB >> 31098563

The impact of acute stroke service centralisation: a time series evaluation.

Mat Elameer1, Chris Price1, Darren Flynn2, Helen Rodgers1.   

Abstract

We evaluated the impact of the centralisation of three acute stroke units into a single hyperacute stroke unit within a large urban and rural NHS trust in North East England in June 2015. We performed retrospective interrupted time series analyses of 4,305 stroke patients admitted between 1 April 2013 and 31 December 2017 utilising data recorded for the Sentinel Stroke National Audit Programme. Centralisation was -associated with reductions in total length of inpatient stay (-4.9 days [95% CI: -8.1 to -1.7]). Time from admission to thrombolysis shortened by 26.0 minutes (95% CI: -40.0 to -12.1), and time from admission to brain imaging for thrombolysed patients improved by 16.2 minutes (95% CI: -22.0 to -10.4). Time from stroke onset to hospital admission, mortality and dependency (as measured by median modified Rankin Scale) were unaffected by centralisation. This study provides further evidence to support the centralisation of acute stroke services in England.

Entities:  

Year:  2018        PMID: 31098563      PMCID: PMC6502604          DOI: 10.7861/futurehosp.5-3-181

Source DB:  PubMed          Journal:  Future Healthc J        ISSN: 2514-6645


  2 in total

1.  Do methods of hospital pre-alerts influence the on-scene times for acute pre-hospital stroke patients? A retrospective observational study.

Authors:  Jacob Gunn
Journal:  Br Paramed J       Date:  2021-09-01

2.  Relationship between primary stroke center volume and time to endovascular thrombectomy in acute ischemic stroke.

Authors:  Laura C C van Meenen; Sanne J den Hartog; Adrien E Groot; Bart J Emmer; Martin D Smeekes; Arjen Siegers; Geert Jan Kommer; Charles B L M Majoie; Yvo B W E M Roos; Adriaan C G M van Es; Diederik W Dippel; H Bart van der Worp; Hester F Lingsma; Bob Roozenbeek; Jonathan M Coutinho
Journal:  Eur J Neurol       Date:  2021-09-23       Impact factor: 6.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.